- Home
- SHLT vs ATRA Comparison
SHLT vs ATRA Comparison
Compare SHLT & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHLT
- ATRA
- Stock Information
- Founded
- SHLT 1987
- ATRA 2012
- Country
- SHLT Israel
- ATRA United States
- Employees
- SHLT N/A
- ATRA N/A
- Industry
- SHLT Business Services
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SHLT Consumer Discretionary
- ATRA Health Care
- Exchange
- SHLT Nasdaq
- ATRA Nasdaq
- Market Cap
- SHLT 49.7M
- ATRA 50.3M
- IPO Year
- SHLT N/A
- ATRA 2014
- Fundamental
- Price
- SHLT $2.81
- ATRA $13.45
- Analyst Decision
- SHLT Strong Buy
- ATRA Hold
- Analyst Count
- SHLT 1
- ATRA 5
- Target Price
- SHLT $11.00
- ATRA $26.88
- AVG Volume (30 Days)
- SHLT 3.5K
- ATRA 134.5K
- Earning Date
- SHLT 09-26-2024
- ATRA 11-12-2024
- Dividend Yield
- SHLT N/A
- ATRA N/A
- EPS Growth
- SHLT N/A
- ATRA N/A
- EPS
- SHLT N/A
- ATRA N/A
- Revenue
- SHLT $55,939,000.00
- ATRA $100,439,000.00
- Revenue This Year
- SHLT N/A
- ATRA $1,190.80
- Revenue Next Year
- SHLT N/A
- ATRA N/A
- P/E Ratio
- SHLT N/A
- ATRA N/A
- Revenue Growth
- SHLT N/A
- ATRA 2111.34
- 52 Week Low
- SHLT $2.54
- ATRA $6.50
- 52 Week High
- SHLT $9.48
- ATRA $39.50
- Technical
- Relative Strength Index (RSI)
- SHLT 41.61
- ATRA 76.28
- Support Level
- SHLT $2.54
- ATRA $11.10
- Resistance Level
- SHLT $3.00
- ATRA $14.93
- Average True Range (ATR)
- SHLT 0.15
- ATRA 1.23
- MACD
- SHLT 0.02
- ATRA 0.46
- Stochastic Oscillator
- SHLT 26.00
- ATRA 91.61
About SHLT SHL Telemedicine Ltd
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).